Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial.
Ramos da Silva Grillo VT, Bertanha M, da Silva Rodrigues L, de Lima MA, Mellucci Filho PL, Rahal Guaragna Machado R, Durigon EL, Dias Sertorio N, de Assis Golim M, Moroz A, Marques Braz AM, de Moraes LN, Leite MA, Bonciani Nader H, de Campos GC, Rodrigues Guzzo Carvalho C, Florença Cardoso F, Magro AJ, Caputo Nunes H, Tommasini Grotto RM, de Cássia Alvarado R, de Moura Campos Pardini MI, Lima Sobreira M, da Costa EAPN, Naime Barbosa A, Fortaleza CMCB.
Ramos da Silva Grillo VT, et al. Among authors: da costa eapn.
Sci Rep. 2024 Aug 27;14(1):19902. doi: 10.1038/s41598-024-70064-8.
Sci Rep. 2024.
PMID: 39191809
Free PMC article.
Clinical Trial.